Research ArticleArticle
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco and José Luis Fernández García
The Journal of Rheumatology March 2021, jrheum.201316; DOI: https://doi.org/10.3899/jrheum.201316
Rebeca Guillén Fajardo
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
Fátima Otero Fariña
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
Alejandro Mosquera Rey
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
Ignacio Rego-Pérez
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
Francisco J. Blanco
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
José Luis Fernández García
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco, José Luis Fernández García
The Journal of Rheumatology Mar 2021, jrheum.201316; DOI: 10.3899/jrheum.201316
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco, José Luis Fernández García
The Journal of Rheumatology Mar 2021, jrheum.201316; DOI: 10.3899/jrheum.201316